Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Akebia Therapeutics Inc
About AKBA
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with two commercial products for patients impacted by kidney disease. The Company's portfolio includes Vafseo and Auryxia. Vafseo is an orally administered medicine, approved by the United States Food and Drug Administration (FDA), for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis for at least three months. Auryxia (ferric citrate) is an orally administered medicine approved and marketed in the United States for two indications: the control of serum phosphorus levels in adult patients with dialysis dependent chronic kidney disease (DD-CKD), and the treatment of iron deficiency anemia (IDA) in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). The Company's development pipeline includes mid-stage rare kidney disease pipeline assets (praliciguat and AKB-097) and early-stage pipeline assets (AKB-9090 and AKB-10108), which are HIF molecules.
Find out what a historical investment in Akebia Therapeutics Inc would be worth today using our AKBA stock calculator.
Market Capitalisation
$250.98M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
0
High today
$0.96
Low today
$0.90
Open price
$0.00
52-week high
$4.08
52-week low
$0.88
Ready to start your investing journey with Stake?
Open an accountHow do I buy AKBA shares in Australia?
Buying AKBA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Akebia Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AKBA
What is the ticker symbol of Akebia Therapeutics Inc?
The ticker symbol for Akebia Therapeutics Inc is AKBA.
How much is one share of AKBA?
One share of AKBA is valued at $0.92 as of 10 June 2026.
What is the market capitalisation of Akebia Therapeutics Inc AKBA?
As of 10 June 2026 Akebia Therapeutics Inc has a market cap of $250.98M.
What is the 52-week high for Akebia Therapeutics Inc stock?
The Akebia Therapeutics Inc 52-week high stock price is $4.08.
What is the 52-week low for Akebia Therapeutics Inc stock?
The Akebia Therapeutics Inc 52-week low stock price is $0.88.
Can I buy AKBA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy AKBA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AKBA on Stake
- Buy AKBA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AKBA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AKBA related stocks